Media Centre

Featured Media Release
 

14 May 2013 - GSK Australia Reports 2012 Results to ASIC

GlaxoSmithKline (GSK) reported to the Australian Securities and Investment Commission (ASIC) for 2012 sales of $1,452m and a total profit before tax of $41m.

 
 

Media Releases


Wake up your whole mouth – with new Macleans® Protect Lemonmint

New Macleans Protect Lemonmint has a refreshing twist of lemon, which leaves the mouth feeling clean and energised after brushing. Best of all, Macleans Protect Lemonmint is also a great family toothpaste, that helps to maintain strong teeth,...

08/12/2006

 

GlaxoSmithKline scientists will provide biomedical research students and fellows, with an insight on career options.

GlaxoSmithKline scientists will provide biomedical research students and fellows, with an insight on the career options available to them in the pharmaceutical industry on November 26, 2006.

09/11/2006

 

Smile, with new Macleans® White & Shine!

Macleans White & Shine is an exciting new toothpaste that whitens and polishes your teeth as you brush, leaving your teeth not only white but so smooth they shine!

08/11/2006

 

Happy birthday, Glaxo!

From milk to medicines, Glaxo has been a recognised name for 100 years.

31/10/2006

 

Polident Fresh Cleanse® – A Breakthrough in Denture Cleansing and Freshening

Introducing Polident fresh cleanse, a unique foaming antibacterial denture cleanser. When you pump Polident fresh cleanse onto your denture, the minty liquid transforms into active foam. With brushing, it microcleans away tough stains and kills...

23/10/2006

 

Tackling the 'Looming Crisis' in Science Education

The Monash Science Centre and GlaxoSmithKline are working together to address the serious decline in science education participation by running a novel program for school age children.

06/09/2006

 

Alzheimer’s disease better understood due to genetic research

Poor glucose utilisation, commonly associated with type 2 diabetes, plays a role in Alzheimer’s disease and researchers are now investigating whether medicines for diabetes may be effective in treating the degenerative brain disease.

10/08/2006

 

Physeptone 10mg tablets supply recommencing

GlaxoSmithKline Australia (GSKA) is pleased to advise that we have resolved the supply issue regarding Physeptone 10mg tablets and that by Friday 2nd June they will be available from pharmacies as per normal.

28/05/2006

 

Supply of Physeptone 10mg tablets

GSK has experienced difficulties with the supply of a raw material that has stopped the manufacture of Physeptone 10mg tablets. Physeptone is used for the relief of chronic pain. We estimate this may affect about 7,000 patients across Australia.

18/05/2006

 

The GlaxoSmithKline Australia Award For Research Excellence.

Australian research is increasing our understanding of cardiovascular disease, the leading cause of premature death in Australia following the identification of key 'master regulator' genes (such as EGR-1) by Professor Levon Khachigian which control...

19/04/2006

< 6 7 8 9 10 11 12 13 14 15 16 >